Three New Zantac Studies Confirm Cancer Risks From:
Los Angeles, Calif., April 6, 2021 - - The results from three new Zantac studies confirm the popular drug contains high levels of a cancer-causing agent (NDMA) and increases the risk of developing several types of cancer. The studies, one from Memorial Sloan Kettering Cancer Center, one from online pharmacy Valisure, and another from the University of Alabama at Birmingham, all found that at a minimum, Zantac (ranitidine) exposes users to substantial amounts of NDMA and may increase the risk of developing:
Bladder cancer
Thyroid cancer One of the things we have said from the very beginning is this litigation is not about a contaminated drug â this drug is defective and dangerous by design,